Retinoic acid downregulates growth, fibronectin and RAR alpha in 3T3 cells: Ha-ras blocks this response and RA metabolism.
Retinoic acid (RA) reduced growth, fibronectin, and retinoic acid receptor (RAR alpha) in NIH 3T3 cells but not in cells transformed by the Ha-ras oncogene. RA lowered RAR alpha transcript and protein, increased RAR beta transcripts, and had no effect on RAR gamma. H-ras transformation downregulated RAR expression and abolished responsiveness to RA. Ha-ras-transformed cells were as active as normal NIH-3T3 cells in RA uptake but were unable to degrade it to medium oxidation product, so that, paradoxically, the resistant cells accumulated 20-30-fold as much RA as the sensitive cells. RA sensitivity/insensitivity correlated with RA metabolism/lack thereof in 15 cell lines in serum-free medium. These data suggest a relationship between RA inhibition of cell growth and intracellular RA metabolism.
De Luca
L M
LM
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Scita
G
G
Takatsuka
J
J
D016475:3T3 Cells / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D005353:Fibronectins / Q000378:metabolism*; D011905:Genes, ras / Q000502:physiology; D051379:Mice; D018168:Receptors, Retinoic Acid / Q000187:drug effects / Q000378:metabolism*; D014212:Tretinoin / Q000378:metabolism / Q000494:pharmacology*
D005353:Fibronectins; D018168:Receptors, Retinoic Acid; D014212:Tretinoin